These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 30674459

  • 1. Complement Gene Variants and Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.
    Frémeaux-Bacchi V, Sellier-Leclerc AL, Vieira-Martins P, Limou S, Kwon T, Lahoche A, Novo R, Llanas B, Nobili F, Roussey G, Cailliez M, Ulinski T, Deschênes G, Alberti C, Weill FX, Mariani P, Loirat C.
    Clin J Am Soc Nephrol; 2019 Mar 07; 14(3):364-377. PubMed ID: 30674459
    [Abstract] [Full Text] [Related]

  • 2. Advances in our understanding of the pathogenesis of hemolytic uremic syndromes.
    Bowen EE, Coward RJ.
    Am J Physiol Renal Physiol; 2018 Mar 01; 314(3):F454-F461. PubMed ID: 29167171
    [Abstract] [Full Text] [Related]

  • 3. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.
    Le Clech A, Simon-Tillaux N, Provôt F, Delmas Y, Vieira-Martins P, Limou S, Halimi JM, Le Quintrec M, Lebourg L, Grangé S, Karras A, Ribes D, Jourde-Chiche N, Rondeau E, Frémeaux-Bacchi V, Fakhouri F.
    Kidney Int; 2019 Jun 01; 95(6):1443-1452. PubMed ID: 30982675
    [Abstract] [Full Text] [Related]

  • 4. Genetic Susceptibility to Postdiarrheal Hemolytic-Uremic Syndrome After Shiga Toxin-Producing Escherichia coli Infection: A Centers for Disease Control and Prevention FoodNet Study.
    Kallianpur AR, Bradford Y, Mody RK, Garman KN, Comstock N, Lathrop SL, Lyons C, Saupe A, Wymore K, Canter JA, Olson LM, Palmer A, Jones TF.
    J Infect Dis; 2018 Mar 05; 217(6):1000-1010. PubMed ID: 29216383
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
    Mahat U, Matar RB, Rotz SJ.
    Pediatr Blood Cancer; 2019 Nov 05; 66(11):e27913. PubMed ID: 31286658
    [Abstract] [Full Text] [Related]

  • 12. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
    Exeni RA, Fernandez-Brando RJ, Santiago AP, Fiorentino GA, Exeni AM, Ramos MV, Palermo MS.
    Pediatr Nephrol; 2018 Nov 05; 33(11):2057-2071. PubMed ID: 29372302
    [Abstract] [Full Text] [Related]

  • 13. [Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient].
    Frémeaux-Bacchi V.
    Biol Aujourdhui; 2013 Nov 05; 207(4):231-40. PubMed ID: 24594571
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.
    Monet-Didailler C, Godron-Dubrasquet A, Madden I, Delmas Y, Llanas B, Harambat J.
    Pediatr Nephrol; 2019 Apr 05; 34(4):657-662. PubMed ID: 30368614
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E, Salmenlinna S, Halkilahti J, Jahnukainen T, Korhonen L, Virkkala T, Rimhanen-Finne R, Nuutinen M, Kataja J, Arikoski P, Linkosalo L, Bai X, Matussek A, Jalanko H, Saxén H.
    Pediatr Nephrol; 2020 Sep 05; 35(9):1749-1759. PubMed ID: 32323005
    [Abstract] [Full Text] [Related]

  • 17. Haemolytic uraemic syndrome associated with non shiga toxin-producing Escherichia coli bacteraemia: a case report.
    Bally S, Fourcade J, Frémeaux-Bacchi V.
    BMC Nephrol; 2019 May 07; 20(1):157. PubMed ID: 31064333
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. C3 levels and acute outcomes in Shiga toxin-related hemolytic uremic syndrome.
    Balestracci A, Meni Bataglia L, Toledo I, Beaudoin L, Alvarado C.
    Pediatr Nephrol; 2020 Feb 07; 35(2):331-339. PubMed ID: 31475299
    [Abstract] [Full Text] [Related]

  • 20. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M, Mariani-Kurkdjian P, Gouali M, de Valk H, King LA, Le Hello S, Bonacorsi S, Loirat C.
    Med Mal Infect; 2018 May 07; 48(3):167-174. PubMed ID: 29054297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.